Copper nanoparticles, due to their interesting properties, low cost preparation and many potential applications in catalysis, cooling fluid or conductive inks, have attracted a lot of interest in recent years. In this study, copper nanoparticles were synthesized through the chemical reduction of copper sulfate with sodium borohydride in water without inert gas protection. In our synthesis route, ascorbic acid (natural vitamin C) was employed as a protective agent to prevent the nascent Cu nanoparticles from oxidation during the synthesis process and in storage. Polyethylene glycol (PEG) was added and worked both as a size controller and as a capping agent. Cu nanoparticles were characterized by Fourier transform infrared (FT-IR) spectroscopy to investigate the coordination between Cu nanoparticles and PEG. Transmission electron microscopy (TEM) and UV–vis spectrometry contributed to the analysis of size and optical properties of the nanoparticles, respectively. The average crystal sizes of the particles at room temperature were less than 10 nm. It was observed that the surface plasmon resonance phenomenon can be controlled during synthesis by varying the reaction time, pH, and relative ratio of copper sulfate to the surfactant. The surface plasmon resonance peak shifts from 561 to 572 nm, while the apparent color changes from red to black, which is partly related to the change in particle size. Upon oxidation, the color of the solution changes from red to violet and ultimately a blue solution appears.
21 April 2011 in Advances in Natural Sciences: Nanoscience and Nanotechnology
A chemical reduction method for preparing colloidal copper nanoparticles in water and ethylene glycol (EG) is reported. The obtained copper nanoparticles were characterized by powder x-ray diffraction (XRD), transmission electron microscopy (TEM) and UV-visible spectrophotometry (UV-vis). Surface plasmon resonance peaks immediately after the synthesis appeared at 579 and 551 nm for the colloidal copper in water and EG, respectively. The stability of colloidal copper in EG was longer than that in water. The color of solution in water changed from light-red to black and the nanoparticles mostly precipitated after 22 days, which is attributed to the oxidation of copper nanoparticles in copper oxide (I), as was confirmed by optical absorption measurements. In EG, copper nanoparticles were red and stable even after 2 months. Ascorbic acid plays a role as antioxidant for colloidal copper, due to its ability to scavenge free radicals and reactive oxygen molecules. Polyvinyl pyrrolidone works both as size controller and polymeric capping agent because it hinders the nuclei from aggregation through the polar groups, which strongly absorb the copper particles on the surface with coordination bonds.
14 July 2011 in Journal of Experimental Nanoscience
We have prepared polymeric drug nanoparticles by oil in water (O/W) emulsion solvent evaporation method. We used acetone as solvent for polymer and water as non-solvent. The purpose of this study is to use the emulsion solvent evaporation method in order to prepare nanoparticles and to investigate the effects of the various processing parameters to the characteristics of the nanoparticles. In this research, we use two different forms of acrylic polymers, Eudragit E100 and Eudragit RS. It was found that the size of the nanoparticles depends on different parameters such as the polymer concentration in the organic solvent, surfactant concentration and the volume ratio of oil and water phases. The morphology structure is investigated by transmission electron microscope (TEM). TEM images confirmed that the nanoparticles produced were spherical in shape and the successfully prepared nanoparticles with size 80 nm. The size distribution is measured by laser dynamic light scattering. The size distribution of the nanoparticles was found in the range from 50 to 150 nm. Investigation of Fourier transform infrared spectroscopy indicated the absence of the interactions between the drug and polymer. X-ray diffraction patterns of nanoparticles containing ketoprofen, Eudragit E100 and Eudragit RS showed the amorphous structure.
12 June 2012 in Advances in Natural Sciences: Nanoscience and Nanotechnology